Adipocytes impair efficacy of antiretroviral therapy;
Couturier, J, Winchester, LC, Suliburk, JW, Wilkerson, GK, Podany, AT, Agarwal, N, Xuan Chua, CY, Nehete, PN, Nehete, BP, Grattoni, A, Sastry, KJ, Fletcher, CV, Lake, JE, Balasubramanyam, A & Lewis, DE 2018, Antiviral Research, vol 154, pp. 140-148. DOI: 10.1016/j.antiviral.2018.04.002

Utilization of Stereotactic Radiosurgery for Renal Cell Carcinoma Brain Metastases;
Haque, W, Verma, V, Butler, EB & Teh, BS 2018, Clinical Genitourinary Cancer. DOI: 10.1016/j.clgc.2018.03.015

Response rates and pathologic complete response by breast cancer molecular subtype following neoadjuvant chemotherapy;
Haque, W, Verma, V, Hatch, S, Suzanne Klimberg, V, Brian Butler, E & Teh, BS 2018, Breast Cancer Research and Treatment, pp. 1-9. DOI: 10.1007/s10549-018-4801-3

SMAD4 gene mutation renders pancreatic cancer resistance to radiotherapy through promotion of autophagy;
Wang, F, Xia, X, Yang, C, Shen, J, Mai, J, Kim, H-C, Kirui, D, Kang, Y, Fleming, JB, Koay, EJ, Mitra, S, Ferrari, M & Shen, H 2018, Clinical Cancer Research. DOI: 10.1158/1078-0432.CCR-17-3435

Acetylation of oxidized base repair-initiating NEIL1 DNA glycosylase required for chromatin-bound repair complex formation in the human genome increases cellular resistance to oxidative stress;
Sengupta, S, Yang, C, Hegde, ML, Hegde, PM, Mitra, J, Pandey, A, Dutta, A, Datarwala, AT, Bhakat, KK & Mitra, S 2018, DNA Repair, vol 66-67, pp. 1-10. DOI: 10.1016/j.dnarep.2018.04.001

Harnessing and Optimizing the Interplay between Immunotherapy and Radiotherapy to Improve Survival Outcomes;
Mujoo, K, Hunt, CR, Pandita, RK, Ferrari, M, Krishnan, S, Cooke, JP, Hahn, S & Pandita, TK 2018, Molecular Cancer Research. DOI: 10.1158/1541-7786.MCR-17-0743

ß1-Integrin Impacts Rad51 Stability and DNA Double-Strand Break Repair by Homologous Recombination;
Ahmed, KM, Pandita, RK, Singh, DK, Hunt, CR & Pandita, TK 2018, Molecular and Cellular Biology, vol 38, no. 9. DOI: 10.1128/MCB.00672-17

Omission of radiotherapy in elderly women with early stage metaplastic breast cancer;
Haque, W, Verma, V, Butler, EB & Teh, BS 2018, Breast, vol 38, pp. 154-159. DOI: 10.1016/j.breast.2018.01.005

Utilization of neoadjuvant intensity-modulated radiation therapy and proton beam therapy for esophageal cancer in the United States;
Haque, W, Verma, V, Butler, EB & Teh, BS 2018, Journal of Gastrointestinal Oncology, vol 9, no. 2, pp. 282-294. DOI: 10.21037/jgo.2017.11.14

Utilization of radiotherapy and stereotactic body radiation therapy for renal cell cancer in the USA;
Haque, W, Verma, V, Lewis, GD, Lo, SS, Butler, EB & Teh, BS 2018, Future Oncology, vol 14, no. 9, pp. 819-827. DOI: 10.2217/fon-2017-0536